Seppic launches Sepifriend

Leveraging its expertise in animal health, cosmetics and nutrition, Seppic expands its portfolio with Sepifriend, a comprehensive range of ingredients dedicated to pet hygiene, care and supplementation. With a global pet population exceeding one billion, the pet care market is experiencing significant growth, with an expected CAGR of 5.7% from 2022 to 2030. This trend is being driven by the increasingly important role that pets play in households, particularly in Europe and the United States. To meet this demand, Seppic, a subsidiary of Air Liquide Healthcare has created Sepifriend, a brand new range of specialty ingredients for pet care products.

Sepifriend offers a complete solution with 11 carefully developed ingredients designed to meet formulators’ needs across pet hygiene, care and supplementation. This line includes foaming and solubilizing agents, rheology modifiers, an emulsifier, an emollient, topical active ingredients with dermo-purifying, soothing and skin repairing functions and, even, a supplementation active ingredient to help address common skin and coat issues in dogs. Seppic ensures that each Sepifriend ingredient undergoes a stringent process, including thorough chemical and toxicological assessments.

A major innovation supporting this safety commitment is the development of an innovative in vitro toxicological model on a reconstructed canine epidermis, developed in collaboration with a partner.